ADVANCED NANOCARRIERS FOR CONTROLLED DRUG AND GENE DELIVERY IN CHRONIC DISEASES
Abstract
Chronic diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders pose significant treatment challenges due to their complexity and resistance to conventional therapies. Nanocarriers, as advanced drug and gene delivery systems, offer a promising solution to address these challenges by providing controlled release, improved targeting, and enhanced therapeutic efficacy. The ability to design nanocarriers that are biocompatible, stable, and capable of precise targeting to diseased tissues holds potential for revolutionizing the treatment of chronic diseases. This study aims to explore the design, development, and evaluation of advanced nanocarriers for controlled drug and gene delivery in chronic diseases. The research focuses on evaluating the efficacy of various nanocarriers, including liposomes, dendrimers, and nanoparticles, in improving drug bioavailability, targeting precision, and therapeutic outcomes in chronic disease models. The research utilizes in vitro cell culture studies and in vivo animal models to assess the effectiveness of different nanocarriers. Characterization techniques, including dynamic light scattering (DLS), transmission electron microscopy (TEM), and drug release assays, are used to evaluate the properties and performance of the nanocarriers. The study demonstrates that advanced nanocarriers significantly improve drug delivery efficiency, reduce systemic toxicity, and enhance therapeutic outcomes in chronic disease models. Gene delivery using nanocarriers also shows promising results in terms of targeted therapy. Advanced nanocarriers are a promising tool for controlled drug and gene delivery, offering potential breakthroughs in the treatment of chronic diseases by improving precision and minimizing side effects.
Full text article
References
Al Yabhouni, S. A., Mozumder, M. S., Hassan, N., Mourad, A.-H. I., & Issa MD, T. M. A. (2024). Nanocarrier-Based, ocular drug delivery: Challenges, prospects, and the therapeutic landscape in the United Arab Emirates. International Journal of Pharmaceutics, 667, 124899. https://doi.org/10.1016/j.ijpharm.2024.124899
Alam, M. A. (2026). Emerging smart nanocarrier based drug delivery systems for cancer therapeutics. Next Nanotechnology, 9, 100387. https://doi.org/10.1016/j.nxnano.2026.100387
Amalraj, A. C., & Parthasarathy, V. (2026). Degraders on Demand: Engineering Smart Nanocarriers for PROTAC Delivery. Molecular Pharmaceutics, 23(2), 622–638. https://doi.org/10.1021/acs.molpharmaceut.5c01070
Amonkar, S. G., & Naik, A. V. (2026). Nanocarrier-assisted phytochemical drug delivery in cancer therapy: A bibliometric analysis and integrative review of challenges, innovations, and translational potential. Pharmacological Research - Reports, 5, 100075. https://doi.org/10.1016/j.prerep.2026.100075
Anwar, M. Z., Kathuria, H., Er, J. X., Wang, Y., & Chiu, G. N. C. (2026). Hybrid hydrogels for biomedical applications: Addressing challenges in drug delivery through advanced crosslinking and nanocarrier integration. Journal of Controlled Release, 392, 114719. https://doi.org/10.1016/j.jconrel.2026.114719
Awasthi, S. (2025). Unveiling the development principles and mechanistic understanding of controlled drug delivery strategies for chronic bone defects and diabetic wound management. Materials Advances, 6(17), 5831–5856. https://doi.org/10.1039/d5ma00490j
Balasubramaniyam, S., Rathinam, T., Srinivasan, M., & Jayarani, S. (2025). Nanocarrier-based insulin delivery: A leap towards a needle-free future. Nano TransMed, 4, 100093. https://doi.org/10.1016/j.ntm.2025.100093
Bhowmik, S., Ghosh, R., & Dev, A. (2026). Advanced disease-responsive materials as intelligent drug delivery systems for rheumatoid arthritis. Journal of Drug Delivery Science and Technology, 115, 107787. https://doi.org/10.1016/j.jddst.2025.107787
Cai, Y., Nie, T., Luo, X., Wu, Y., & Wu, J. (2026). Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics. Acta Biomaterialia, 212, 103–123. https://doi.org/10.1016/j.actbio.2026.01.043
Chennamsetty, S., Keerikkadu, M., Shetty, A., Bangera, P. D., Tippavajhala, V. K., & Rathnanand, M. (2026). Biohybrid nanocarriers for targeted drug delivery by integrating biological interfaces with synthetic platforms for site-specific therapeutics. International Journal of Pharmaceutics, 687, 126400. https://doi.org/10.1016/j.ijpharm.2025.126400
Das, M., & Parhi, R. (2025). Nanocarriers and their integrated microneedle systems-mediated drug delivery for the treatment of moderate-severe dermatological diseases: Recent progress, applications and future perspectives. Journal of Drug Delivery Science and Technology, 106, 106748. https://doi.org/10.1016/j.jddst.2025.106748
Elsherbini, A. M., Mohamed, S. A., Zayed, A. M., Mohamed, W. A., & Sabra, S. A. (2026). Obesity-associated pathologies: Recent advances in stimuli-responsive nanocarriers for adipose tissue browning and beyond. OpenNano, 28, 100290. https://doi.org/10.1016/j.onano.2026.100290
Goswami, A. K., Sarma, A., Ahmed, S., & Das, B. K. (2025). Linalool in chronic diseases: A comprehensive review of its pharmacological potential and delivery aspects. Fitoterapia, 185, 106754. https://doi.org/10.1016/j.fitote.2025.106754
Gunjal, T., Mule, S., Gunjal, K., Gaur, S., Singh, J., Nagingar, A., Maru, R., & Maru, S. (2026). Nanocarriers for drug delivery in skin cancer. In Advances in Cancer Research. Academic Press. https://doi.org/10.1016/bs.acr.2026.01.003
Hadkar, V. M., Mohanty, C., & Selvaraj, C. I. (2024). Biopolymeric nanocarriers in cancer therapy: Unleashing the potency of bioactive anticancer compounds for enhancing drug delivery. RSC Advances, 14(35), 25149–25173. https://doi.org/10.1039/d4ra03911d
Hallajisani, M., Pourmadadi, M., Yazdian, F., Rashedi, H., Rahdar, A., & Pandey, S. (2026). Next-gen aspirin: Smart nanocarriers for targeted and controlled therapeutic delivery. Journal of Drug Delivery Science and Technology, 115, 107664. https://doi.org/10.1016/j.jddst.2025.107664
Hassan, A., Zameer, M. D., Khan, M., Hassan, T., Umair, M., Iqbal, M. N., Ahi, M. J., Gul, P., & Ahmed, N. (2026). Smart nanocarriers for biosimilars: A new frontier in targeted drug delivery. Journal of Drug Delivery Science and Technology, 116, 107955. https://doi.org/10.1016/j.jddst.2025.107955
Hussain, S., Arif, A., Mujeeb-ur-Rehman, & Shah, M. R. (2026). Targeted drug delivery: Designing nanocarriers for improved therapeutic action. Chemical Communications, 62(23), 6232–6256. https://doi.org/10.1039/d5cc07306e
Jiao, Y., Zuo, H., Wang, F., Chen, W., & Wu, J. (2025). Delivery strategies based on surface-modified nanocarriers conjugated with biomolecular ligands targeting liver receptors. Colloids and Surfaces B: Biointerfaces, 256, 115051. https://doi.org/10.1016/j.colsurfb.2025.115051
Kamyab, H., Jamalpour, S., Khalili, E., & Rajendran, S. (2026). Advances in nanocarrier-based nose-to-brain drug delivery systems for neurological disorders—A comprehensive review. Powder Technology, 474, 122244. https://doi.org/10.1016/j.powtec.2026.122244
Keerikkadu, M., Shetty, A., Bangera, P. D., Tippavajhala, V. K., & Rathnanand, M. (2026). Hybrid transferosomes as multifunctional nanocarriers for enhanced targeted therapy and theranostic drug delivery in complex diseases. Journal of Drug Delivery Science and Technology, 115, 107819. https://doi.org/10.1016/j.jddst.2025.107819
Khaki, N., Ekhlasi, A., Shahryari, E., Nazarpak, M. H., & Nouri, A. (2026). Bioceramic and carbon-based nanocarriers: Advanced platforms for targeted and stimuli-responsive drug delivery. Smart Materials in Manufacturing, 4, 100131. https://doi.org/10.1016/j.smmf.2026.100131
Liu, J., Cabral, H., & Mi, P. (2024). Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release. Advanced Drug Delivery Reviews, 207, 115239. https://doi.org/10.1016/j.addr.2024.115239
Ma, Y., Lan, Z., Zhong, L., Zhao, M., Luo, Y., Xiang, T., & Zhou, S. (2026). Application of nanomaterials in the treatment of diabetes and its complications: As nanocarriers or with inherent therapeutic functions. Biomaterials Advances, 183, 214783. https://doi.org/10.1016/j.bioadv.2026.214783
Mishra, A. S., Ghosh, B., Malliappan, S. P., Dutta, G., & Vasanthan, M. (2026). Formulation approaches for colon-specific drug delivery: Conventional to nanocarrier systems. RSC Advances, 16(11), 10022–10059. https://doi.org/10.1039/d5ra05194k
Mostafa, M. M., Mosallam, S., Eltaweel, M. M., Amin, M. M., & Abd El-Halim, S. M. (2026). NSAIDs-loaded nanocarriers as emerging anticancer therapeutics: Harnessing inflammation-targeted drug delivery to combat tumor progression. International Journal of Pharmaceutics, 694, 126751. https://doi.org/10.1016/j.ijpharm.2026.126751
Noreen, S., Maqbool, I., Saleem, A., Mahmood, H., & Rai, N. (2025). Recent insights and applications of nanocarriers-based drug delivery systems for colonic drug delivery and cancer therapy: An updated review. Critical Reviews in Oncology/Hematology, 208, 104646. https://doi.org/10.1016/j.critrevonc.2025.104646
Paul, S., Mukherjee, S., & Banerjee, P. (2023). Recent advancement in nanomaterial-encapsulated drug delivery vehicles for combating cancer, COVID-19, and HIV-like chronic diseases. Materials Advances, 4(9), 2042–2061. https://doi.org/10.1039/d2ma01075e
Qutub, M., Tatode, A., Iqbal, Z., Hussain, U. M., Taksande, J., Khan, R., Thakre, D., Premchandani, T., Umekar, M., & Sheikh, S. (2025). Stimuli-responsive nanovesicles for spatiotemporal control of drug delivery in chronic cutaneous wounds: Bridging molecular pathobiology to translational nanomedicine. Journal of Drug Delivery Science and Technology, 112, 107238. https://doi.org/10.1016/j.jddst.2025.107238
Rajabi, M., & Feyzbakhsh, H. (2025). Polymeric nanocarriers in drug delivery, bioimaging, and biosensing: Advances and perspectives on nanomicelles, nanogels, and dendrimers. RSC Advances, 15(48), 40400–40438. https://doi.org/10.1039/d5ra05399d
Rizg, W. Y., Alghamdi, M. A., Saadany, S. E., Madkhali, O. A., Nair, A. K., Rashid, M. A., & Kotta, S. (2025). Recent advances and future prospects of engineered exosomes as advanced drug and gene delivery systems. Journal of Drug Delivery Science and Technology, 106, 106696. https://doi.org/10.1016/j.jddst.2025.106696
Singh, M., Singh, S., Sharma, P., Bhandari, R., Sharma, N., Rajput, R., Gupta, V., Singh, S. K., Dua, K., Chitranshi, N., & Basu, S. (2026). Smart Lipid-Based Nanocarrier System for the Topical Delivery of Ocular Therapeutics Bio-Interfacing, Physicochemical Diversity, and Routing Barriers. European Journal of Pharmaceutical Sciences, 107506. https://doi.org/10.1016/j.ejps.2026.107506
Ssengooba, F., Skosana, P. P., Demana, P. H., Makoni, P. A., & Witika, B. A. (2026). Nanotechnology-enabled therapeutics for liver health: Preventing injury and advancing disease management through targeted drug delivery. Journal of Drug Delivery Science and Technology, 117, 108077. https://doi.org/10.1016/j.jddst.2026.108077
Unagolla, J. M., Das, S., Flanagan, R., Oehler, M., & Menon, J. U. (2024). Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives. International Journal of Pharmaceutics, 660, 124381. https://doi.org/10.1016/j.ijpharm.2024.124381
Vojdanitalab, K., Naderi, M., Ghorbani Kalkhajeh, S., Sabetghadam, A., & Rouhani Pashaki, S. (2026). Brain targeted drug delivery using liposomes and polymeric nanocarriers: Pharmaceutical and preclinical perspectives in Alzheimer’s and Parkinson’s disease. Journal of Drug Delivery Science and Technology, 120, 108200. https://doi.org/10.1016/j.jddst.2026.108200
Zhu, C., Pu, Y., & Liang, L. (2026). Learn from nature: Biomimetic nanocarriers for intracellular protein delivery. Bioactive Materials, 55, 658–678. https://doi.org/10.1016/j.bioactmat.2025.09.048
Authors
Copyright (c) 2026 Ren Suzuki, Daiki Nishida, Nila Trisna Yulianti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
